The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[7-[6-(1,7-diazaspiro[4.4]nonan-7-yl)-5-methyl-3-pyridyl]imidazo[1,2-a]pyridin-3-yl]-2-methyl-quinoline ID: ALA4757547
PubChem CID: 139326584
Max Phase: Preclinical
Molecular Formula: C30H30N6
Molecular Weight: 474.61
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2cnc3cc(-c4cnc(N5CCC6(CCCN6)C5)c(C)c4)ccn23)c2ccccc2n1
Standard InChI: InChI=1S/C30H30N6/c1-20-14-23(17-32-29(20)35-13-10-30(19-35)9-5-11-33-30)22-8-12-36-27(18-31-28(36)16-22)25-15-21(2)34-26-7-4-3-6-24(25)26/h3-4,6-8,12,14-18,33H,5,9-11,13,19H2,1-2H3
Standard InChI Key: IPEFWZSKBRMPLL-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 42 0 0 0 0 0 0 0 0999 V2000
14.4059 -15.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9932 -14.4207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1905 -14.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1071 -15.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8583 -15.7424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5601 -17.0372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5601 -17.8585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2696 -18.2671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2696 -16.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9748 -17.0372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9748 -17.8550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7528 -18.1065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2353 -17.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7528 -16.7859 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8495 -16.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8485 -15.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1363 -15.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4246 -15.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4297 -16.6402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1424 -17.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7111 -15.4049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7476 -18.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0353 -19.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0298 -20.1414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7351 -20.5552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4495 -19.3322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4467 -20.1432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1465 -20.5494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8497 -20.1457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8486 -19.3315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1481 -18.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3193 -20.5452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1343 -14.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6211 -14.5903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8159 -14.4211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9582 -15.7448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 1 0
6 9 2 0
7 8 2 0
8 11 1 0
10 9 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
6 15 1 0
18 21 1 0
12 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 27 1 0
26 22 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 26 2 0
24 32 1 0
17 33 1 0
21 34 1 0
34 35 1 0
35 1 1 0
1 36 1 0
36 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 474.61Molecular Weight (Monoisotopic): 474.2532AlogP: 5.56#Rotatable Bonds: 3Polar Surface Area: 58.35Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 10.61CX LogP: 4.17CX LogD: 1.24Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.37Np Likeness Score: -0.61
References 1. Engers DW,Bollinger SR,Felts AS,Vadukoot AK,Williams CH,Blobaum AL,Lindsley CW,Hong CC,Hopkins CR. (2020) Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors., 30 (18): [PMID:32750526 ] [10.1016/j.bmcl.2020.127418 ]